Adenosine Injection, Solution
Product Images NDC 71288-208

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 71288-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (60 mg per 20 mL Carton)

Package Label.principal Display Panel (60 mg per 20 mL Carton)
This is a product label for an Injection, USP with a concentration of 60mg per 20 mL. The expiration date mentioned is '10/20/21'.*
FDA Label Image

Package Label.principal Display Panel (60 mg per 20 mL Container Label)

Package Label.principal Display Panel (60 mg per 20 mL Container Label)
This text appears to be a label from a medication package. It indicates that the product is Adenosine Injection meant for intravenous infusion only. The recommended dose is mentioned as "mg per 20mL". The vial is sterile and nonpyrogenic with a discard instruction for any unused portion. The product comes in a 20 mL single-dose vial with identification details such as NDC 71288-207- 1? provided.*
FDA Label Image

Package Label.principal Display Panel (90 mg per 30 mL Carton)

Package Label.principal Display Panel (90 mg per 30 mL Carton)
This text appears to be a label for a medication product called Adenosine Injection, USP, with a concentration of 3mg per mL in a single-dose vial of 30 mL. It is specified for intravenous infusion only and must be discarded if unused. The solution contains adenosine and sodium chloride in water, with a pH range between 4.5 and 7.5. The usual dosage and storage instructions are provided, along with details about the manufacturer, Meitheal Pharmaceuticals. Additionally, the label mentions that the container closure does not contain natural rubber latex, and the solution is sterile and nonpyrogenic. The text also indicates to dissolve any crystallization before use and emphasizes that the solution needs to be clear at the time of administration.*
FDA Label Image

Package Label.principal Display Panel (90 mg per 30 mL Container Label)

FDA Label Image

Structural Formula (Adenosine Structure)

FDA Label Image

General Formula (Adrenosine Formula)

General Formula (Adrenosine Formula)
This is a formula used to calculate the infusion rate of adenosine based on the individual's total body weight and the concentration of adenosine solution provided in the text. The formula involves multiplying 0.14 (mg/kg/min) with the total body weight in kilograms and then dividing by the adenosine concentration (3 mg/mL) to determine the infusion rate in mL/min.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.